Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:21-Hydroxypregnenolone)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST000509 AN000780 Metabolic changes to maternal rat liver tissue during and post-pregnancy Liver Rat University of Colorado, Denver Arbitrary units
ST001639 AN002683 Plasma Metabolomic signatures of COPD in a SPIROMICS cohort Blood Human COPD National Jewish Health AU
ST001403 AN002345 Ontogeny related changes in the pediatric liver metabolome (part-II) Liver Human Moffitt Cancer Center estimated abundances
ST002155 AN003530 Longitudinal metabolomic stool dynamics in primary C. difficile infections Feces Human Bacterial infection Brigham Women's Hospital intensity
ST002459 AN004012 Comparison of metabolite profiles from matched whole blood microsamplers, whole blood dried blood spots, and plasma. Blood Human Icahn School of Medicine at Mount Sinai Ion abundance
ST002829 AN004621 Nucleotide, phospholipid, and kynurenine metabolites are robustly associated with COVID-19 severity and time of plasma sample collection in a prospective cohort study Blood Human COVID-19 National Institutes of Health log transformed data
ST001940 AN003155 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles Metabolon original scale
ST001940 AN003156 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles Metabolon original scale
ST001940 AN003157 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles Metabolon original scale
ST001940 AN003158 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles Metabolon original scale
ST000148 AN000235 A549 13C-labeled Cell Study Epithelial cells Human Cancer University of Kentucky normalized corrected peak area
ST002020 AN003290 TIPs Metabolomics (urine) Urine Human Vanderbilt University Medical Center osmolality normalized scaled imputed
ST002498 AN004656 Plasma Metabolomics Profiling of 580 Patients from the Weill Cornell Medicine Early Detection Research Network Prostate Cancer Cohort Blood Human Cancer Weill Cornell Medicine peak area
ST001212 AN002046 Fish-oil supplementation in pregnancy, child metabolomics and asthma risk Blood Human Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen Peak area
ST001411 AN002361 Plasma metabolites of lipid metabolism associate with diabetic polyneuropathy in a cohort with screen-tested type 2 diabetes: ADDITION-Denmark Blood Human Obesity University of Michigan Peak area
ST001412 AN002362 Metabolomics study in Plasma of Obese Patients with Neuropathy Identifies Potential Metabolomics Signatures Blood Human Obesity University of Michigan Peak area
ST002977 AN004889 Offline Two-dimensional Liquid Chromatography-Mass Spectrometry for Deep Annotation of the Fecal Metabolome following Fecal Microbiota Transplant Feces Human University of Michigan Peak area
ST003520 AN005780 Identification of Plasma Metabolomic Biomarkers of Juvenile Idiopathic Arthritis Blood Human Arthritis University of Kansas Peak area
ST002909 AN004777 Plasma metabolomics reveals distinct biological and diagnostic signatures for melioidosis Blood Human Melioidosis University of Washington Peak Area
ST001827 AN002963 The pregnancy metabolome from a multi-ethnic pregnancy cohort Blood Human Icahn School of Medicine at Mount Sinai pmoles/l
ST000899 AN001464 Alterations in Lipid, Amino Acid, and Energy Metabolism Distinguish Crohn Disease from Ulcerative Colitis and Control Subjects by Serum Metabolomic Profiling Blood Human Inflammatory bowel disease Vanderbilt University Medical Center raw area counts
ST001400 AN002341 Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria Blood Human Malaria New York University Abu Dhabi raw area counts
ST001516 AN002516 Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria (part-II) Blood Human Malaria New York University Abu Dhabi raw area counts
ST001517 AN002519 Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria (part-III) Blood Human Malaria New York University Abu Dhabi raw area counts
ST001749 AN002850 REACH Metabolomics Study Blood Human Alzheimers disease University of Wisconsin - Madison Raw area counts
ST002818 AN004588 Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (ALTOLD) Blood Human Tufts Medical Center raw area counts rescaled to set the median equal to 1
ST002819 AN004592 Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (MDRD) Blood Human Tufts Medical Center raw area counts rescaled to set the median equal to 1
ST002820 AN004596 Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (AASKG1) Blood Human Tufts Medical Center raw area counts rescaled to set the median equal to 1
ST001404 AN002346 Ontogeny related changes in the pediatric liver metabolome (part-III) Liver Human Moffitt Cancer Center Relative Abundance
ST002088 AN003408 Plasma Metabolomic signatures of COPD in a SPIROMICS cohort: A metabolomic severity score for airflow obstructions and emphysema Blood Human COPD National Jewish Health relativeMedian
ST002089 AN003412 Plasma metabolomic signatures of COPD: A metabolomic severity score for airflow obstruction and emphysema. Blood Human COPD National Jewish Health relativeMedian
ST002017 AN003287 Multi-omic analysis of the microbiome and metabolome in healthy subjects (blood) Blood Human Vanderbilt University Medical Center scaled imputed
ST002018 AN003288 Multi-omic analysis of the microbiome and metabolome in healthy subjects (feces) Feces Human Vanderbilt University Medical Center scaled imputed
ST002019 AN003289 TIPs Metabolomics (blood) Blood Human Vanderbilt University Medical Center scaled imputed
ST000974 AN001595 GC6-74 matabolomic of TB (Part 1: Plasma) Blood Human Tuberculosis Max Planck Institute for Infection Biology scaled units
ST000975 AN001596 GC6-74 metabolomics of TB vs healthy (Part 2: Serum) Blood Human Tuberculosis Max Planck Institute for Infection Biology scaled units
ST000976 AN001597 GC6-74 matabolomic of TB (Part 3: Plasma_RPMI) Blood Human Tuberculosis Max Planck Institute for Infection Biology scaled units
ST001515 AN002513 A Metabolomic Signature of Glucagon Action in Healthy Individuals with Overweight/Obesity Humans Blood Human Obesity Translational Research Institute- AdventHealth Orlando scaled units
  logo